Concepedia

Louis E. Metzger

LE

Statistics

Publications

17

Citations

662

H-Index

16

Active since

2003

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

Duke University

Duke Medical Center

Duke University Hospital

Louis E. Metzger is an author at Novartis (United States) specializing in life sciences, microbiology, and drug discovery.

Publications per year

2003–2024

17

Publications

17

Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in Aged Mice

Carolina Cano Macip, Rokib Hasan, Victoria Hoznek et al. · Cellular Reprogramming · 2024 · 68 citations · Full text

, , +17

Different Poses for Ligand and Chaperone in Inhibitor-Bound Hsp90 and GRP94: Implications for Paralog-Specific Drug Design

Robert M. Immormino, Louis E. Metzger, Patrick N. Reardon et al. · Journal of Molecular Biology · 2009 · 67 citations · Full text

, , +16

Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae – Identification of LYS228

Folkert Reck, Alun Bermingham, Johanne Blais et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 58 citations · Full text

, , +13

An Alternative Route for UDP-Diacylglucosamine Hydrolysis in Bacterial Lipid A Biosynthesis

Louis E. Metzger, Christian R.H. Raetz · Biochemistry · 2010 · 53 citations

, , +17

Toxic Accumulation of LPS Pathway Intermediates Underlies the Requirement of LpxH for Growth of Acinetobacter baumannii ATCC 19606

Daryl L. Richie, Kenneth T. Takeoka, Jade Bojkovic et al. · PLoS ONE · 2016 · 48 citations · Full text

, , +15

1–5 of 17